-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Dizicf7e351qkMRpsoUlYjhuWW5sU2tOPD+QM0IbUSf9EgDDOVbZXVj/HRwFDHNA YT9KC+PS04gQw+yL5FVgOw== 0000713275-10-000002.txt : 20100202 0000713275-10-000002.hdr.sgml : 20100202 20100202112623 ACCESSION NUMBER: 0000713275-10-000002 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100127 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20100202 DATE AS OF CHANGE: 20100202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMOS CORP CENTRAL INDEX KEY: 0000713275 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363207413 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-11550 FILM NUMBER: 10565587 BUSINESS ADDRESS: STREET 1: 99 WOOD AVENUE SOUTH STREET 2: SUITE 311 CITY: ISELIN STATE: NJ ZIP: 08830 BUSINESS PHONE: 7324529556 MAIL ADDRESS: STREET 1: 99 WOOD AVENUE SOUTH STREET 2: SUITE 311 CITY: ISELIN STATE: NJ ZIP: 08830 FORMER COMPANY: FORMER CONFORMED NAME: PHARMATEC INC DATE OF NAME CHANGE: 19920703 8-K 1 currentreport.htm CURRENT REPORT currentreport.htm


SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549


FORM 8-K
CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported)    January 27, 2010


PHARMOS CORPORATION
(Exact name of Registrant as Specified in its Charter)

 
Nevada
0-11550
36-3207413
  
 
(State or Other Jurisdiction of Incorporation)
(Commission file Number)
(IRS Employer Identification No.)
  


99 Wood Avenue South, Suite 311, Iselin, NJ
08830
(Address of Principal Executive Offices)
(Zip Code)

 
Registrant’s telephone number, including area code (732) 452-9556


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]  Soliciting material pursuant to Rule 14a-2 under the Exchange Act (17 CFR 240.14a-2)

[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 
 

Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 27, 2010, the Compensation and Stock Option Committee of the Board of Directors of Pharmos Corporation, taking into account that no bonuses were awarded for 2008, approved the following cash bonuses for 2009 performance: $80,000 for each of Robert F. Johnston, the company’s Executive Chairman, and S. Colin Neill, the company’s President and Chief Financial Officer.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 2nd day of February, 2010.


PHARMOS CORPORATION


By:            /s/ S. Colin Neill                                                      
Name:  S. Colin Neill
Title:  President and Chief Financial Officer


 -----END PRIVACY-ENHANCED MESSAGE-----